HARBOROUGH FIELD SURGERY
160 NEWTON ROAD, RUSHDENHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 24 | 30 | 80.0% | |
HF 4 | 2011 | 20 | 28 | 71.4% | |
HF 4 | 2012 | 26 | 34 | 76.5% | |
HF 4 | 2013 | 25 | 29 | 86.2% | |
HF004 | 2014 | 24 | 27 | 88.9% | |
HF004 | 2015 | 27 | 28 | 96.4% | |
HF004 | 2016 | 41 | 45 | 91.1% | |
HF004 | 2017 | 55 | 63 | 87.3% | |
HF004 | 2018 | 75 | 88 | 85.2% | |
HF004 | 2019 | 86 | 94 | 91.5% | |
HF004 | 2020 | 82 | 94 | 87.2% | |
HF006 | 2021 | 99 | 115 | 86.1% | |
HF006 | 2022 | 100 | 108 | 92.6% | |
HF006 | 2023 | 99 | 104 | 95.2% |